| Haleos Labs Limited | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 540679 |
NSE Symbol : HALEOSLABS |
P/E(TTM) : 23.06 |
|
ISIN Demat : INE320X01016 |
Div & Yield% : 0.11 |
EPS(TTM) : 58.80 |
|
Book Value(₹) : 709.74 |
Market Cap(₹Cr) : 409.96 |
Face Value(₹) : 10.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 63.38 | 80.72 | 77.84 | 79.04 | 85.43 | 82.88 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 63.38 | 80.72 | 77.84 | 79.04 | 85.43 | 82.88 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.97 | 0.08 | 0.44 | 1.01 | 2.20 | 0.06 |
| Total Income | 64.35 | 80.80 | 78.28 | 80.05 | 87.63 | 82.94 |
| Total Expenditure | 57.18 | 69.16 | 67.04 | 68.21 | 79.83 | 69.81 |
| PBIDT | 7.17 | 11.64 | 11.24 | 11.85 | 7.80 | 13.13 |
| Interest | 1.34 | 1.46 | 1.51 | 1.73 | 1.84 | 1.96 |
| PBDT | 5.83 | 10.18 | 9.73 | 10.11 | 5.96 | 11.17 |
| Depreciation | 2.66 | 2.69 | 2.68 | 2.63 | 2.62 | 2.56 |
| Tax | -0.93 | 2.00 | 2.00 | 2.25 | 1.00 | 2.31 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 1.87 | 0.08 | 0.07 | 0.07 | -0.34 | 0.07 |
| Reported Profit After Tax | 2.23 | 5.41 | 4.98 | 5.16 | 2.68 | 6.23 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 2.23 | 5.41 | 4.98 | 5.16 | 2.68 | 6.23 |
| EPS (Unit Curr.) | 7.39 | 17.88 | 16.46 | 17.06 | 8.85 | 20.60 |
| EPS (Adj) (Unit Curr.) | 7.39 | 17.88 | 16.46 | 17.06 | 8.85 | 20.60 |
| Calculated EPS (Unit Curr.) | 7.39 | 17.88 | 16.46 | 17.06 | 8.85 | 20.60 |
| Calculated EPS (Adj) (Unit Curr.) | 7.39 | 17.88 | 16.46 | 17.06 | 8.85 | 20.60 |
| Calculated EPS (Ann.) (Unit Curr.) | 29.57 | 71.54 | 65.86 | 68.24 | 35.39 | 82.39 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 29.57 | 71.54 | 65.86 | 68.24 | 35.39 | 82.39 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 15.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 3.02 | 3.02 | 3.02 | 3.02 | 3.02 | 3.02 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 11.31 | 14.42 | 14.44 | 14.99 | 9.13 | 15.84 |
| PBDTM(%) | 9.20 | 12.61 | 12.50 | 12.79 | 6.98 | 13.48 |
| PATM(%) | 3.52 | 6.70 | 6.40 | 6.53 | 3.14 | 7.52 |
